• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

TM CRUX UK Fund B Acc

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund Provider Thesis Unit Trust Management Limited
Fund Summary The investment objective of the Fund is to achieve long-term growth, which should be seen as five years plus, through both capital appreciation and income generation. There is no guarantee that the Fund will achieve a positive return over this, or any other, period and investors may not get back the original amount they invested. In seeking to achieve the Fund's objective, the portfolio will consist predominantly (75% or greater) of companies listed on a UK equities exchange which are incorporated or domiciled in the UK. The investments will be ordinary shares and other transferable securities including, but not limited to, preference shares and debt securities convertible into ordinary stocks and shares. The Fund may also invest in cash, money market instruments, deposits, warrants, units in other collective investment schemes and derivatives. The Fund will typically consist of between 20 and 40 holdings and may also invest in companies which are not listed, incorporated or domiciled in the UK if the investment manager believes that they should be beneficial for the Fund. Investors attention is drawn to the detailed risk warnings in this Prospectus. The Fund will be managed in a manner that maintains eligibility for ISAs.
SEDOL code B5839S6
ISIN GB00B5839S67
Fund code WBUBA
Managers Jamie Ward
Manager Tenure 3 years
Morningstar Category UK Large-Cap Equity
IMA Sector UK All Companies
Fund Size £66 million
Fund Type OEIC
Management Style Active
Ongoing Charge Figure (OCF) 0.96%
Cavendish ongoing charge 0.05%
FundsNetwork Service Fee 0.20%
Minimum Initial Investment £25
Minimum Top Up £25
Minimum Monthly Investment £25
Sell Price £2.4764
Buy Price £2.4764
Price Change +0.6258%
Price Date 6th December 2019
Yield 1.83%
Dividend Frequency Semi-Annually
ISA Eligible Yes
SIPP Eligible Yes
Inception Date 8th December 2014
Fund Status OPEN

3-year Mean Monthly Return: 0.710%

Annual Returns 2018 2017 2016 2015 2014 2013 2012 2011
Fund Performance +8.27% +4.24% +11.25% +21.29% +0.19% +5.62% +21.02% +21.96%
Benchmark Performance
(UK Large-Cap Equity)
+1.80% +5.06% +11.54% +13.90% -0.99%
Time Period Cumulative Benchmark Performance
(UK Large-Cap Equity)
Fund Compared to Benchmark
1 day 0.63% +14.12% -13.49%
1 week -2.43% -0.64% -1.79%
1 month -0.76% +1.46% -2.22%
3 months 0.32% +3.14% -2.83%
6 months 3.27% +13.07% -9.80%
1 year 15.63% +6.30% +9.33%
3 years 7.89% +5.50% +2.39%
5 years 7.34% +7.01% +0.33%
10 years Currently unavailable Currently unavailable Currently unavailable
YTD 17.14% -1.97% +19.11%
Since inception 9.16% Currently unavailable Currently unavailable

Top 10 shares for this fund

Share Name Country Value
GlaxoSmithKline PLC GBR 5.05%
British American Tobacco PLC GBR 4.93%
Daily Mail and General Trust PLC Class A GBR 4.90%
Barclays PLC GBR 4.87%
BP PLC GBR 4.72%
HSBC Holdings PLC GBR 4.67%
PZ Cussons PLC GBR 4.19%
Standard Chartered PLC GBR 4.13%
Experian PLC USA 3.81%
Schroders PLC GBR 3.79%
Dividend Date Per share amount Reinvestment Price
1st October 2019 0.0115 £2.4917
1st April 2019 0.0269 £2.3085
1st October 2018 0.0311 £2.3068
2nd July 2018 0.0220 £2.3134
2nd January 2018 0.0178 £2.2692
3rd July 2017 0.0248 £2.1862